Search research articles
Contact Us
Filters
Showing results (121-130 of 150) with videos related to
Page
of 15
Sort By:
Nursing Reports (Pavia, Italy)
|
June 25, 2025
Embracing Growth, Adaptability, Challenges, and Lifelong Learning: A Qualitative Study Examining the Lived Experience of Early Career Nurses
Liz Ryan, Di Stratton-Maher, Jessica Elliott, et al.
Practical Radiation Oncology
|
May 8, 2022
Oligometastatic Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Chemotherapy With Nonoperative Intent of the Primary for Locoregional Complete Responders
Joshua P Schiff, Re-I Chin, Amit Roy, et al.
Canadian Respiratory Journal
|
July 23, 2016
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
Christopher J Ryerson, Benjamin Tan, Charlene D Fell, et al.
International Journal of Nursing Studies
|
February 25, 2026
Re-imagining nursing education: Mapping student learning, transition, and workforce readiness - A scoping review
Dianne Stratton-Maher, Tracey Tulleners, Jessica Elliott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2024
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in <i>PIK3CA</i>-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
Jonathan A Nowak, Tyler Twombly, Chao Ma, et al.
The Oncologist
|
June 18, 2020
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma
James J Harding, Robin K Kelley, Benjamin Tan, et al.
JAMA Oncology
|
January 26, 2023
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer
En Cheng, Qian Shi, Anthony F Shields, et al.
JAMA
|
April 6, 2021
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial
Jeffrey A Meyerhardt, Qian Shi, Charles S Fuchs, et al.
JCO Precision Oncology
|
October 5, 2020
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay
Katherine Clifton, Thereasa A Rich, Christine Parseghian, et al.
JAMA Oncology
|
December 4, 2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial
George Q Zhang, Jeffrey A Meyerhardt, Qian Shi, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 150) with videos related to
Sort By:
Page
of 15
Nursing Reports (Pavia, Italy)
|
June 25, 2025
Embracing Growth, Adaptability, Challenges, and Lifelong Learning: A Qualitative Study Examining the Lived Experience of Early Career Nurses
Liz Ryan, Di Stratton-Maher, Jessica Elliott, et al.
Practical Radiation Oncology
|
May 8, 2022
Oligometastatic Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Chemotherapy With Nonoperative Intent of the Primary for Locoregional Complete Responders
Joshua P Schiff, Re-I Chin, Amit Roy, et al.
Canadian Respiratory Journal
|
July 23, 2016
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
Christopher J Ryerson, Benjamin Tan, Charlene D Fell, et al.
International Journal of Nursing Studies
|
February 25, 2026
Re-imagining nursing education: Mapping student learning, transition, and workforce readiness - A scoping review
Dianne Stratton-Maher, Tracey Tulleners, Jessica Elliott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2024
Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in <i>PIK3CA</i>-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance)
Jonathan A Nowak, Tyler Twombly, Chao Ma, et al.
The Oncologist
|
June 18, 2020
Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma
James J Harding, Robin K Kelley, Benjamin Tan, et al.
JAMA Oncology
|
January 26, 2023
Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer
En Cheng, Qian Shi, Anthony F Shields, et al.
JAMA
|
April 6, 2021
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial
Jeffrey A Meyerhardt, Qian Shi, Charles S Fuchs, et al.
JCO Precision Oncology
|
October 5, 2020
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay
Katherine Clifton, Thereasa A Rich, Christine Parseghian, et al.
JAMA Oncology
|
December 4, 2025
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib: A Post Hoc Analysis of the CALGB (Alliance)/SWOG 80702 Phase 3 Randomized Clinical Trial
George Q Zhang, Jeffrey A Meyerhardt, Qian Shi, et al.
Page
of 15